This is the authors' abstract. We don't add key points for this paper.
Varenicline seems to be more efficacious in certain subgroups, particularly in those who reduced their smoking and in the "less severe" patient. Additional studies are warranted to confirm the results of these exploratory analyses.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Falk et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: